Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · IEX Real-Time Price · USD
1.630
+0.010 (0.62%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Unity Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Revenue
0.244.7800000
Revenue Growth (YoY)
-95.07%------
Gross Profit
0.244.7800000
Selling, General & Admin
20.9523.0624.0320.0516.029.625.14
Research & Development
36.8638.3967.3170.9658.9137.3713.71
Other Operating Expenses
002.6-1.354.5400
Operating Expenses
57.8161.4593.9389.6579.4746.9918.84
Operating Income
-57.57-56.67-93.93-89.65-79.47-46.99-18.84
Interest Expense / Income
3.563.181.290002.18
Other Expense / Income
-1.20.88-1.38-7.47-3.07-2.339.38
Pretax Income
-59.93-60.73-93.84-82.18-76.4-44.66-30.4
Net Income
-59.93-60.73-93.84-82.18-76.4-44.66-30.4
Shares Outstanding (Basic)
9654300
Shares Outstanding (Diluted)
9654300
Shares Change
70.10%9.73%16.60%54.32%784.12%20.08%-
EPS (Basic)
-6.31-10.88-18.45-18.80-27.00-139.70-114.20
EPS (Diluted)
-6.31-10.88-18.45-18.80-27.00-139.70-114.20
Free Cash Flow
-50.75-45.26-78.98-74.01-57.89-40.05-18.64
Free Cash Flow Per Share
-5.34-8.11-15.53-16.96-20.48-125.24-70.01
Gross Margin
100.00%100.00%-----
Operating Margin
-24394.92%-1184.47%-----
Profit Margin
-25392.80%-1269.34%-----
Free Cash Flow Margin
-21502.97%-945.97%-----
EBITDA
-54.19-54.67-89.1-79.51-74.22-43.35-28.07
EBITDA Margin
-22961.44%-1142.73%-----
Depreciation & Amortization
2.182.883.452.662.181.30.15
EBIT
-56.37-57.55-92.55-82.18-76.4-44.66-28.22
EBIT Margin
-23885.17%-1202.93%-----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).